top of page

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Mistabron 200mg Injection

Mistabron 200mg Injection

Manufacturer/Marketed By : DR REDDY'S LABORATORIES LTD

$17.36 $13.89

Sidmex Inovia offers bulk export supply of Mistabron 200mg Injection (MESNA) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and tenders:...

MESNA

Active Pharmaceutical Ingredient

Mistabron 200mg Injection

SKU MISTABRON-200MG-INJECTION
Original price

$17.36

Sale price

$13.89

Sidmex Inovia offers bulk export supply of Mistabron 200mg Injection (MESNA) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.

Documents, cold-chain shipping and tenders: see our Export FAQ.

Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada

Related products we supply: Alburel 20 gm/100 ml Injection

Mistabron 200mg injection contains the active substance Mesna. It is a cytoprotective drug that belongs to the class of hemorrhagic cystitis inhibitors. This medicine reduces the risk of hemorrhagic cystitis (a condition that causes bladder inflammation and can result in serious bleeding) in people who receive ifosfamide (a medication used for treating cancer). It protects against some of the harmful effects of certain chemotherapy medications. Do not take this injection if you are allergic to Mistabron 200mg injection or any other ingredients of this medicine. This medicine can cause serious allergic reactions and skin reactions. Inform your doctor if you face any symptoms of fever, swelling of your face, lips, mouth, or tongue, trouble breathing or wheezing, itching, burning, skin rash or hives, skin redness, or swelling after taking this medicine. Notify your physician if you are pregnant or breastfeeding or have severe liver and bladder problems. Female patients should use effective contraception during the treatment with Mistabron 200mg injection in combination with other anticancer medication and for 6 months after the last dose. The most common side effects are nausea, vomiting, constipation, decreased platelets and WBC levels, tiredness, fever, abdominal pain, headache, hair loss, and difficulty sleeping.

Active Pharmaceutical Ingredient

MESNA

Uses

• Hemorrhagic cystitis

Benefits

Mistabron 200mg injection reduces ifosfamide (cancer medication) induced hemorrhagic cystitis by binding to certain metabolites, inhibiting their toxic effects on the bladder.

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Most Common Side Effects

• Rash
• Hypersensitivity reactions

Common Side Effects

• Chest pain
• Swelling in the face, feet, and hands
• Hair loss
• Excessive sweating
• Decreased potassium levels
• Abdominal pain
• Constipation
• Diarrhea, loss of appetite
• Nausea, vomiting
• Anemia
• Changes in the blood count levels
• Backache
• Confusion, dizziness, headache
• Fever, tiredness

How To Use

It should only be administered by a trained doctor or nurse experienced in administering chemotherapy. The medicine will be given as an infusion into a vein. Do not self-administer the injection. Your doctor will decide the dose and duration of the treatment based on your disease severity and other factors.

Safety Advice

• Breast Feeding: Breastfeeding is not recommended in patients taking Mistabron 200mg injection because the medicine secrete into the breast milk in small amounts and may harm your baby.
• Alcohol: It is unknown whether consuming alcohol will affect the effectiveness of Mistabron 200mg injection. Consult your doctor for more advice.
• Liver: Mistabron 200mg injection should be cautiously administered in patients with severe liver diseases. Dose adjustments are necessary. Inform your physician if you have liver problems before initiating the therapy.
• Lungs: It is unknown whether Mistabron 200mg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.
• Driving: Mistabron 200mg injection affects the ability to drive or operate heavy machines. It is unsafe to drive or operate heavy machinery.
• Pregnancy: There are limited human studies on the safety of Mistabron 200mg injection during pregnancy. Consult your doctor if you are pregnant, suspecting, or planning for pregnancy.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page